Олександр Петрович Шматенко

Олександр Петрович Шматенко

Auto-generated profile, based on publicly available information

Олександр Петрович Шматенко

Ukrainian military medical academy

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2020 in Ukrainian Journal of Military Medicine
Verified
Journal Article
Open access
PDF file
OSO.P. Shmatenko
O.P. Shmatenko
OPO.V. Pidlisny
O.V. Pidlisny
TPT.V. Prykhodko
T.V. Prykhodko
ASA.M. Solomennyi
A.M. Solomennyi
RPR.L. Pritula
R.L. Pritula
NTN.O. Takhtaulova
N.O. Takhtaulova
Introduction. Treatment of wounds and wound infection is an important issue for the military medicine system and the national health care system of Ukraine. At the present stage the main approaches in the purulent wounds treatment are the pathogenetic orientation in accordance with the phase of the wound process. It includes: debridement, additional treatment of the postoperative wound, early closure of the wound defect, wound drainage, antibacterial therapy, elimination of the factors that slow down healing. The leading role in topical treatment belongs to soft dosage forms – ointments, creams, gels, which provide high therapeutic efficacy antiseptic, antibiotics, anti-inflammatory and reparative drugs in the affected area with minimal side effects. Purpose of the study - analysis of modern technological aspects of creating soft dosage forms for the treatment of purulent wounds. Materials and methods: national and international scientific literature used in the work; methods of systematic analysis and biblical semantic research applied in the work. Results.The approaches of the State Pharmacopoeia of Ukraine, the European Pharmacopoeia, the US Pharmacopoeia and the integrated classifications proposed by a number of scientists to the classification of soft dosage forms are summarized. The main pharmaceutical factors influencing the efficacy and quality of soft dosage forms are determined: physical properties of active pharmaceutical ingredients and excipients, nature and amount of base-carrier and excipients that are part of the drug, type of dosage form and technological operations carried out during its manufacture. Bases-carriers are important components of soft dosage forms, as they account for 90% or more of the total weight and affect the activity of the pharmaceutical ingredients and the rheological properties of the dosage form. It is determined that in accordance with the requirements of the State Pharmacopoeia of Ukraine, the classification of the bases of soft drugs is carried out on the basis of affinity for water and the type of dispersed system. The US Pharmacopoeia uses additional differentiation by the ability to absorb water, which leads to the allocation of four classes of bases for ointments: hydrocarbon, absorbent, water-washable and water-soluble. The analysis of research results showed that clinically justified for the local treatment of the wound process is the use of ointments based on hydrophilic and emulsion bases, which are characterized by dehydrating action and the ability to effectively conduct active pharmaceutical ingredients to wound canals and cavities. Conclusions. Soft dosage forms have a leading role in the local treatment of purulent wounds, as they ensure the achievement of the optimal concentration of active pharmaceutical ingredients in the affected area, providing high therapeutic efficacy and prolonged action with minimal side effects of the components. Pharmaceutical factors are crucial for the development of soft dosage forms for the treatment of purulent wounds: the physical properties of drugs, the nature and amount of base-carrier and excipients that are part of the drug, the type of dosage form and technological operations performed in its manufacture. At the present stage, it is advisable to develop complex drugs for certain phases of the wound process, which can simultaneously affect several factors of pathogenesis. It is determined that for the treatment of purulent wounds in the first phase of the wound process it is advisable to use soft dosage forms with strong and prolonged osmotic activity, in the second phase - with moderate osmotic activity, in the third phase of the wound process dosage forms should prevent drying of the wound surface, protect and stimulate growth of granulations.

5 February 2024 in Zaporozhye Medical Journal
Verified
Journal Article
Open access
PDF file
KMKateryna Miedviedieva
Kateryna Miedviedieva
RPR. L. Prytula
R. L. Prytula
OSO. P. Shmatenko
O. P. Shmatenko
BIBushueva Володимирівна Inna
Bushueva Володимирівна Inna
VPVolodymyr Parchenko
Volodymyr Parchenko
SVS. O. Vasiuk
S. O. Vasiuk
Foot fungus (Candida, molds, dermatophytes) is a fairly common problem. According to the WHO, one-fifth of the world’s population is affected by fungal skin diseases. The prevalence of mycosis of the feet, which affects every second person, is especially increasing. Such a pathology can appear quite unexpectedly and at an inappropriate time. Today, Ukraine is under aggressive pressure from its northern neighbor, and military personnel are not only constantly at risk of receiving combat injuries and wounds, but also due to active hostilities, they may not have access to the necessary hygiene products, get cold, overheat in the sun, or not have time to change their clothes in time. and shoes. The reality is the absence or delay of treatment; the disease progresses and can spread quickly. If mycosis has appeared in one soldier, it can quickly affect others. Therefore, the problem of providing medical and pharmaceutical care is an urgent issue today. Expanding the assortment of drugs with the above action will ensure the needs of the Armed Forces and civilian patients with this dermatological pathology. It will be able to optimize antifungal therapy regimens. For quite a long time, 1,2,4-triazole derivatives have been a promising class of organic compounds that attract the attention of scientists from various fields. It has been proven that 2-(((3-(2-fluorophenyl)-5-thio-4H-1,2,4-triazole-4-yl)imino)methyl)phenol has high antifungal activity. A potential medicinal product based on this medicinal substance can be used for the treatment of various dermatological diseases. To continue the creation of new effective dosage forms for the effective therapy of mycosis of the feet, the urgent task of today is the development of an express, accurate, reliable, and affordable method of quantitative determination of the substance under study. The aim of the work is to develop an express, sensitive and easy-to-implement UV-method for the quantitative determination of 2-(((3-(2-fluorophenyl)-5-thio-4H-1,2,4-triazole-4-yl)imino)methyl)phenol. Materials and methods. The research object is a working standard sample of 2-(((3-(2-fluorophenyl)-5-thio-4H-1,2,4-triazole-4-yl)imino)methyl)phenol provided by NUNVF, LLC “Brovapharma” according to the “Research and production technological regulations for the production of 2-(((3-(2-fluorophenyl)-5-thio-4H-1,2,4-triazol-4-yl)imino)methyl)phenol” developed based on scientific developed by the Ukrainian Military Medical Academy in conjunction with the National Military Medical Clinical Center “Main Military Clinical Hospital” (term of validity of the regulations until 12/31/2034). Isopropanol of grade “chemically pure” was used as a solvent. Analytical equipment: spectrophotometer Specord 200, electronic scales Radwag XA 210.4Y, class A measuring vessels. Results. An express, eco-friendly spectrophotometric method was developed for the quantification of 2-(((3-(2-fluorophenyl)-5-thio-4H-1,2,4-triazole-4-yl)imino)methyl)phenol in isopropanol area, having analytically maximum at 310 nm. The studied solutions are stable for 30 minutes. The analytical technique is linear in the range of concentrations 0.440–0.754 mg/100 ml (70–130 %). The detection and quantification limits were 5.80 % and 15.70 % respectively. The score was 0.76, according to the “greenness” icon of the analytical technique, using the tools AGREE. The prediction of the total uncertainty of the results of the developed method is 1.70 % (max∆As 2.00 %). The proposed method is relevant according to the requirements of the State Pharmacopoeia of Ukraine. Conclusions. Pharmaceutical development, introduction into industrial production and further prescribing by dermatovenerologists of an effective, safe, and harmless medicinal product will help to expand the range and reduce the level of high import dependence of the domestic market of medicinal products, which will create a more complete and balanced system of medicinal supply in Ukraine and optimize antifungal therapy schemes.

30 March 2024 in Ukrainian Journal of Military Medicine
Verified
Journal Article
Open access
PDF file
RPR. L. Prytula
R. L. Prytula
OSO. P. Shmatenko
O. P. Shmatenko
BIBushueva Володимирівна Inna
Bushueva Володимирівна Inna
VPVolodymyr Parchenko
Volodymyr Parchenko
OYO. K. Yerenko
O. K. Yerenko
DDD. V. Drozdov
D. V. Drozdov
Purpose: to systematize the scientific literature data on the antifungal activity of 1,2,4-triazole derivatives and, based on a systematic analysis of scientific sources, to identify the most promising area for further research. Materials and methods. We conducted an information search of scientific sources describing the antifungal activity of 1,2,4-triazole derivatives, analyzed the data of scientific sources to determine the spectrum of antifungal activity of 1,2,4-triazole derivatives, their mechanisms of action, as well as the scope of their application, and applied the bibliosemantic method (study and analysis of terminology, concepts and categories used in the scientific literature to describe the antifungal activity of 1,2,4-triazole derivatives), the systematic method (study of the antifungal activity of 1,2,4-triazole derivatives as an integral system, taking into account the interrelationships between its various elements), the descriptive method (description and systematization of data on the antifungal activity of 1,2,4-triazole derivatives), and the generalization of the study results and formulation of conclusions. The research materials used were scientific articles, monographs, patents, and dissertations containing information on the antifungal activity of 1,2,4-triazole derivatives and their applications. Conclusions. 1,2,4-triazole derivatives are a promising class of antifungal compounds. Further research in this area may lead to the development of new effective antifungal drugs. Toxicity, drug resistance, and occasional lack of desired drug efficacy create an urgent need for research and development of new antifungal drugs. Accordingly, the analysis of literary sources can provide the following strategies for expanding the scope of application of "chemical frameworks" as antifungal agents: development of new chemicals for selective fungal targeting; repurposing available drugs as antifungal agents; combined therapy; development of hybrid antifungal agents affecting two or more fungal targets. Метою нашого дослідження було систематизувати дані наукової літератури про протигрибкову активність похідних 1,2,4-триазолу та, на основі системного аналізу наукових джерел, визначити найперспективніший напрямок для подальших наукових досліджень. Матеріали і методи дослідження. Було проведено інформаційний пошук наукових джерел, що описують протигрибкову активність похідних 1,2,4-триазолу, аналіз даних наукових джерел для визначення спектра протигрибкової дії похідних 1,2,4-триазолу, їх механізмів дії, а також сфери їх застосування, застосовано бібліосемантичний метод (вивчення та аналіз термінології, понять та категорій, що використовуються в науковій літературі для опису протигрибкової активності похідних 1,2,4-триазолу), системний метод (дослідження протигрибкової активності похідних 1,2,4-триазолу як цілісної системи, з урахуванням взаємозв'язків між різними її елементами), описовий метод (опис та систематизація даних про протигрибкову активність похідних 1,2,4-триазолу), та проведено узагальнення результатів дослідження та формулювання висновків. У якості матеріалів дослідження було використано наукові статті, монографії, патенти, дисертації, що містять інформацію про протигрибкову активність похідних 1,2,4-триазолу та сфери їх застосування. Висновки. Похідні 1,2,4-триазолу є перспективним класом протигрибкових сполук. Подальші дослідження в цій галузі можуть призвести до розробки нових ефективних протигрибкових препаратів. Токсичність, резистентність до ліків і випадкова відсутність бажаної ефективності ліків викликають нагальну потребу в дослідженні та розробці нових протигрибкових ліків. Відповідно, проведений аналіз літературних джерел може надати наступні стратегії щодо розширення сфери застосування «хімічних каркасів» як протигрибкових засобів: розробка нових хімічних речовин для селективної грибкової мішені.. Перепрофілювання доступних препаратів як протигрибкових засобів. Комбінована терапія. Розробка гібридних протигрибкових агентів, що вражають дві або більше грибкових мішеней.

30 March 2024 in Ukrainian Journal of Military Medicine
Verified
Journal Article
Open access
PDF file
MOM. V. Ohloblina
M. V. Ohloblina
BIBushueva Володимирівна Inna
Bushueva Володимирівна Inna
OSO. P. Shmatenko
O. P. Shmatenko
VPVolodymyr Parchenko
Volodymyr Parchenko
TKT. V. Khortetska
T. V. Khortetska
OPO. V. Plіeshkova
O. V. Plіeshkova
Вступ. Сучасний процес створення оригінальних ліків охоплює широкий спектр досліджень, у тому числі післяреєстраційних. У 2022 році на ветеринарному ринку лікарських препаратів України з’явився сучасний оригінальний вітчизняний ветеринарний препарат у вигляді 10% лініменту «Ветмікодерм». Діюча речовина препарату належить до похідних 1,2,4-триазолу - (4-((5-(децилтіо)-4-метил-4H-1,2,4-триазол-3-іл)-метил)морфолін). Похідні 1,2,4-триазолу відомі як малотоксичні біологічно активні сполуки для лікування дерматологічних захворювань, активність яких залежить від фармакофорних замісників. Подальше дослідження препарату «Ветікодерм» є доцільним для розширення показань та вдосконалення препарату. Мета роботи – проведення in silico дослідження 4-((5-(децилтіо)-4-метил-4H-1,2,4-триазол-3-іл)-метил)морфоліну, а також його вплив на деякі штами мікроорганізмів, що в комплексі може розширити перелік показань до застосування препарату «Ветмікодерм 10 %». Матеріали та методи. Структуру 4-((5-(децилтіо)-4-метил-4Н-1,2,4-триазол-3-іл)метил)морфоліну намальовано і переведено у форматі SMILES за допомогою MarvinSketch. Прогноз білкових мішеней біоактивного ліганду проводився на базі веб-сервісу Galaxy. Дослідження антимікробних властивостей 4-((5-(децилтіо)-4-метил-4Н-1,2,4-триазол-3-іл)метил)морфоліну проведені на 13 штамах мікроорганізмів за температури 37°С. Гравіметричні вимірювання виконували на лабораторних електронних аналітичних вагах моделі ESJ-200-4 (США). Результати. Структура ліганду 4-((5-(децилтіо)-4-метил-4Н-1,2,4-триазол-3-іл)метил)морфоліну перетворено у формат SDF за допомогою OpenBabel. Ліганд додатково піддавали мінімізації енергії за допомогою Chimera. Рентгенівські кристалічні структури білків з спільно кристалізованими лігандами були отримані з Protein Data Bank (PDB). Для виконання дослідження стикування білка та лігандів та їх конвертації у формат pdbqt використовувався плагін DockingPie Vina в PyMOL. Для підтвердження протоколу докінгу було проведено валідацію. Для генерації зображень комплексів рецептор-ліганд були використані програми PyMOL v.2.5 та Discovery Studio Visualizer. Докінг-дослідження 4-((5-(децилтіо)-4-метил-4Н-1,2,4-триазол-3-іл)метил)морфоліну проводили на шести обраних ферментах та білках. Докінг показав, що сполука має потенціал для зв’язування з тимідин кіназою (PDB: 4IVR) при енергії зв’язку -7.292 kcal/mol (0.348 μM), з тіамін фосфат синтазою (PDB: 1G6C) та біотин карбоксилазою (PDB: 2W6O) з енергією зв’язку -7.221 та -6.074 kcal/mol відповідно. Було досліджено антибактеріальну активність 4-((5-(децилтіо)-4-метил-4H-1,2,4-триазол-3-іл)-метил)морфоліну in vitro за стандартною добре відомою методикою. Усі концентрації дослідного зразку (0,1; 0,5 та 1,0%) володіють бактерицидною дією проти Staphylococcus aureus UNСSM-017 (11,5; 14,7 та 16,5 мм) у порівнянні з контролем (Стрептоміцин, 16,2 мм). Визначено бактеріостатичну дію 1,0% розчину дослідного зразка на польовий штам Pseudomonas aeruginosa (6,3 мм). Повільна зона затримки росту 0,5 та 1,0% зразка сполуки на Bacillus subtilis АТСС №6633 (4,0; 4,1 мм) проти контролю (11,9 мм). Висновки. Біоактивний ліганд вірогідно може проявляти антибактеральну та противірусну дію через інгібування молекулярних і біологічних процесів патогенних організмів. Обрані цільові мішені мали прийнятні режими зв’язування з 4-((5-(децилтіо)-4-метил-4Н-1,2,4-триазол-3-іл)метил)морфоліном, не утворювали небажаних контактів та взаємодіяли з деякими критично важливими амінокислотними...

11 October 2021 in Ukrainian Journal of Military Medicine
Verified
Journal Article
Open access
PDF file
TOT. M. Ostashchenko
T. M. Ostashchenko
OSO. P. Shmatenko
O. P. Shmatenko
MBM. V. Bilous
M. V. Bilous
OGO. V. Galan
O. V. Galan
DDD. V. Drozdov
D. V. Drozdov
Introduction. At present, the further course of Ukraine's development is aimed at Euro-Atlantic integration. According to the State Program for Reforming and Development of the Armed Forces of Ukraine for the period up to 2020, a unified efficient logistics system was created and the medical support system of the Armed Forces of Ukraine was improved in accordance with NATO standards. In addition, certain functions of medical supplies were transferred to the logistics system of the Armed Forces of Ukraine. Thus, the issues of military logistics are relevant today for the Medical Forces of the Armed Forces of Ukraine. The purpose. Analyzing the existing approaches to the interpretation of the term "military logistics" in the historical aspect and researching its essence in accordance with the modern conditions of functioning the Medical Forces of the Armed Forces of Ukraine. Materials and methods. To achieve the goal of the research, an analysis of foreign and domestic scientific literature and the current regulatory framework of Ukraine was carried out. Research methods are information retrieval, comparison, systematization, analysis and synthesis. Results. Based on the analysis, it has been established that the term "military logistics" is still in constant development and in a certain historical period. In the process of evolution of scientific approaches to the conduct of military operations, military logistics was also formed. And new logistics systems emerged, innovative methods and tools were used to support the armed forces. Several definitions of the term "military logistics" are given in chronological order. It was found that some authors, using different terminology, consider the same essence or phenomenon of this category. This indicates that the researcher belongs to various logistics schools or focuses his attention on certain aspects of the logistics process or the system as a whole. Conclusions. Based on the analysis of existing approaches to the interpretation of the term "military logistics" in the historical aspect, it was determined that the concept of military logistics is an important component in planning and implementing the movement, ensuring the vital activity of troops (forces) in peacetime and a special period, as well as integral part of supporting military operations. The essence of the concept of military logistics is investigated in accordance with the modern conditions of the functioning of the Medical Forces of the Armed Forces of Ukraine. The need for the formation of a unified logistic approach to the provision of the Armed Forces of Ukraine with medical equipment and property is determined, taking into account the legal norms established in the legislation regarding the circulation of medicines and medical devices, as well as the licensing system in the field of pharmaceutical activities. The expediency of creating a unified effective medical supply management system of the Armed Forces of Ukraine, taking into account the logistic approach, under the unified leadership of the Commander of the Medical Forces of the Armed Forces of Ukraine has been substantiated. It is noted that the integration of the main constants of military logistics, both in the military health care system as a whole and in its pharmaceutical sector, led to the creation of military pharmaceutical logistics as part of the medical logistics of the Armed Forces of Ukraine.

30 June 2025 in Ukrainian Journal of Military Medicine
Verified
Journal Article
Open access
PDF file
KIK. K. Isaycheva
K. K. Isaycheva
AKAndrii Kaplaushenko
Andrii Kaplaushenko
YSYu. G. Sameliuk
Yu. G. Sameliuk
OSO. P. Shmatenko
O. P. Shmatenko
ASA. M. Solomennyi
A. M. Solomennyi
Introduction. This article presents an analysis of the antioxidant activity of 4-amino-5-(2-, 3-, 4-nitrophenyl)-1H-1,2,4-triazole-3-thiones and their synthetic analogues, 5-(4-methoxyphenyl, 3,4,5-trimethoxyphenyl)-1,2,4-triazole-3-thiones and their synthetic analogues, and 5-(quinolin-2-yl, 2-hydroxyquinolin-4-yl)-4-R1-1,2,4-triazole-3-thiones. The main conclusions drawn from these studies are as follows: The purpose: to evaluate the antioxidant activity of 1,2,4-triazole derivatives, specifically 4-amino-5-(2-, 3-, 4-nitrophenyl)-1H-1,2,4-triazole-3-thiones, 5-(4-methoxyphenyl-, 3,4,5-trimethoxyphenyl)-1,2,4-triazole-3-thiones, and 5-(quinolin-2-yl-, 2-hydroxyquinolin-4-yl)-4-R₁-1,2,4-triazole-3-thiones, in order to identify promising compounds with pronounced antioxidant activity for potential use in the correction of pathological conditions associated with oxidative stress, particularly among the military personnel of the Armed Forces of Ukraine. Materials and Methods: The study involved the synthesis and structural analysis of 1,2,4-triazole derivatives. The antioxidant activity was assessed using spectrophotometric and electrochemical methods, determining the ability of the studied compounds to neutralize free radicals and inhibit oxidative processes. The influence of chemical structure, particularly the nature of substituents at positions 4 and 5 of the triazole ring, on antioxidant properties was analyzed through a comparative study of the obtained results. Results. Derivatives of 5-R-3-thio-1,2,4-triazole show promise as potential matrices for the development of highly effective antioxidant agents. The antioxidant properties of these derivatives depend on the nature of the substituents at the 4 and 5 positions of the 1,2,4-triazole ring. The presence of a free SH group and its substituted products, such as thioacetic acids, their salts, and esters, also contribute to the antioxidant effect. Compounds with a greater number of electron-donating groups exhibit the highest antioxidant activity, highlighting the importance of these groups in providing effective protection against oxidative processes. Conclusions. The results of the conducted study confirm the potential of 1,2,4-triazole derivatives as compounds with antioxidant activity and provide an important scientific basis for further structural optimization to enhance their effectiveness. The obtained data contribute to the development of novel highly active antioxidant agents for the correction of pathological conditions associated with oxidative stress, particularly among the military personnel of the Armed Forces of Ukraine.